Liquidia Technologies LQDA 深 滬
等待開盤 09-20 09:30:00 美东时间
10.27
+0.360
+3.63%
華盛通- 最 高10.48
- 今 開10.10
- 成交量 105.91万股
- 最 低 9.91
- 昨 收 9.91
- 總市值 8.67亿
- 52周最高 16.99
- 市盈率 靜 --
- 換手率 1.26%
- 52周最低 5.71
- 委 比 98.53%
- 總股本 8437.80万
- 歷史最高 38.46
- 量 比 0.97
- 振 幅 5.75%
- 歷史最低 2.25
- 每 手 1
- 風險率 3.07%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多快讯 | liquidia公司：美国联合医疗在针对FDA的诉讼中提交了新的反诉，重新提出对FDA接受公司Yutrepia新药申请的挑战
Liquidia Corp: United Therapeutics Filed New Cross-Claims in FDA Suit Against F...
09-18 05:17
快讯 | Liquidia打算捍卫其推出Yutrepia的能力，并且捍卫自己免受United的指控。
Liquidia- Intends to Defend Its Ability to Launch Yutrepia & to Defend Itse...
09-18 05:17
Liquidia stock rises after it prices public and private offering
Liquidia (NASDAQ:LQDA) said it has priced its underwritten public offering and private placement, which is expected to raise $67.5 million. The firm has offered 6.46M shares at $8.9 apiece. The compan...
09-11 20:47
Liquidia requests preliminary injunction against FDA for Tyvaso 3-year exclusivity
Liquidia (NASDAQ:LQDA) late on Aug. 27 filed a request for a preliminary injunction against the U.S. FDA in a District of Columbia federal court regarding the agency's granting of 3-year exclusivity f...
08-29 01:12
Liquidia to Present at Upcoming Investor Conferences
MORRISVILLE, N.C., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASD...
08-28 20:00
Needham Reiterates Buy on Liquidia, Maintains $19 Price Target
Needham analyst Serge Belanger reiterates Liquidia (NASDAQ:LQDA) with a Buy and maintains $19 price target.
08-23 00:02
Liquidia Analyst Ratings
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-23 00:00
Buy Rating Affirmed: Liquidia Technologies’ Proactive Legal Strategies and Favorable Outlook
Serge Belanger, an analyst from Needham, maintained the Buy rating on Liquidia ...
08-22 22:05
Liquidia challenges exclusivity blocking Yutrepia in new lawsuit
Liquidia Corporation (NASDAQ:LQDA) announced Thursday a lawsuit challenging the recent FDA decision to grant a three-year exclusivity to Tyvaso DPI from United Therapeutics (UTHR), which it said had d...
08-22 20:39
快讯 | Liquidia股份在市场开盘前下跌2.7%，此前该公司质疑对手呼吸道药物的监管独家性。
Liquidia Shares Down 2.7% Premarket After Co Challenges Regulatory Exclusivity ...
08-22 18:52
